FABP4 as a therapeutic host target controlling SARS-CoV-2 infection.
Baazim H, Koyuncu E, Tuncman G, Burak MF, Merkel L, Bahour N, Karabulut ES, Lee GY, Hanifehnezhad A, Karagoz ZF, Földes K, Engin I, Erman AG, Oztop S, Filazi N, Gul B, Ceylan A, Cinar OO, Can F, Kim H, Al-Hakeem A, Li H, Semerci F, Lin X, Yilmaz E, Ergonul O, Ozkul A, Hotamisligil GS.
Baazim H, et al. Among authors: lin x.
EMBO Mol Med. 2025 Jan 22. doi: 10.1038/s44321-024-00188-x. Online ahead of print.
EMBO Mol Med. 2025.
PMID: 39843629